BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Garcovich M, Zocco MA, Roccarina D, Ponziani FR, Gasbarrini A. Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota. World J Gastroenterol 2012; 18(46): 6693-6700 [PMID: 23239905 DOI: 10.3748/wjg.v18.i46.6693]
URL: https://www.wjgnet.com/1007-9327/full/v18/i46/6693.htm
Number Citing Articles
1
Alba Moratalla, Javier Ampuero, Pablo Bellot, Rocío Gallego‐Durán, Pedro Zapater, Manuela Roger, Blanca Figueruela, Belén Martínez‐Moreno, José M. González‐Navajas, José Such, Manuel Romero‐Gómez, Rubén Francés. Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathyLiver International 2017; 37(2): 212 doi: 10.1111/liv.13200
2
Gregory P. Donaldson, S. Melanie Lee, Sarkis K. Mazmanian. Gut biogeography of the bacterial microbiotaNature Reviews Microbiology 2016; 14(1): 20 doi: 10.1038/nrmicro3552
3
Zeeshan Butt, Nauman A. Jadoon, Osman N. Salaria, Kamran Mushtaq, Irbaz B. Riaz, Ahmed Shahzad, Ali M. Hashmi, Shahid Sarwar. Diabetes mellitus and decompensated cirrhosis: Risk of hepatic encephalopathy in different age groups (糖尿病与失代偿性肝硬化:不同年龄组的肝性脑病风险)Journal of Diabetes 2013; 5(4): 449 doi: 10.1111/1753-0407.12067
4
Lan-Jing Wang, Xin Yao, Qi Qi, Jian-Ping Qin. Prevention and treatment of hepatic encephalopathy during the perioperative period of transjugular intrahepatic portosystemic shuntWorld Journal of Gastrointestinal Surgery 2023; 15(8): 1564-1573 doi: 10.4240/wjgs.v15.i8.1564
5
David W. Victor, Eamonn M.M. Quigley. Hepatic Encephalopathy Involves Interactions Among the Microbiota, Gut, BrainClinical Gastroenterology and Hepatology 2014; 12(6): 1009 doi: 10.1016/j.cgh.2014.01.022
6
Rajan Singh, Hannah Zogg, Lai Wei, Allison Bartlett, Uday C Ghoshal, Singh Rajender, Seungil Ro. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic DisordersJournal of Neurogastroenterology and Motility 2021; 27(1): 19 doi: 10.5056/jnm20149
7
Jingjing Li, Zujiang Yu, Qiongye Wang, Duolu Li, Bin Jia, Yubing Zhou, Yanwei Ye, Shen Shen, Yanfang Wang, Shasha Li, Lu Bai, Quancheng Kan. Hyperammonia induces specific liver injury through an intrinsic Ca2+-independent apoptosis pathwayBMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-151
8
Pavlo Petakh, Valentyn Oksenych, Iryna Kamyshna, Iryna Boisak, Katerina Lyubomirskaya, Oleksandr Kamyshnyi. Exploring the complex interplay: gut microbiome, stress, and leptospirosisFrontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1345684
9
Xiao Wei, Shan Jiang, Xiangna Zhao, Huan Li, Weishi Lin, Boxing Li, Jing Lu, Yansong Sun, Jing Yuan. Community-Metabolome Correlations of Gut Microbiota from Child-Turcotte-Pugh of A and B PatientsFrontiers in Microbiology 2016; 7 doi: 10.3389/fmicb.2016.01856
10
Philipp Schindler, Leon Seifert, Max Masthoff, Arne Riegel, Michael Köhler, Christian Wilms, Hartmut H. Schmidt, Hauke Heinzow, Moritz Wildgruber. TIPS Modification in the Management of Shunt-Induced Hepatic Encephalopathy: Analysis of Predictive Factors and Outcome with Shunt ModificationJournal of Clinical Medicine 2020; 9(2): 567 doi: 10.3390/jcm9020567
11
Lauren R. Heinzinger, Angus Johnson, Jenna I. Wurster, Rachael Nilson, Swathi Penumutchu, Peter Belenky. Oxygen and Metabolism: Digesting Determinants of Antibiotic Susceptibility in the GutiScience 2020; 23(12): 101875 doi: 10.1016/j.isci.2020.101875
12
Suraphan Panyod, Wei-Kai Wu, Kuan-Hung Lu, Chun-Ting Liu, Yung-Lin Chu, Chi-Tang Ho, Wen-Luan Wendy Hsiao, Yi-Syuan Lai, Wei-Cheng Chen, Yu-En Lin, Shi-Hang Lin, Ming-Shiang Wu, Lee-Yan Sheen. Allicin Modifies the Composition and Function of the Gut Microbiota in Alcoholic Hepatic Steatosis MiceJournal of Agricultural and Food Chemistry 2020; 68(10): 3088 doi: 10.1021/acs.jafc.9b07555
13
J. S. Bajaj. Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosisAlimentary Pharmacology & Therapeutics 2016; 43(S1): 11 doi: 10.1111/apt.13435
14
Jasmohan S. Bajaj, Giovanni Barbara, Herbert L. DuPont, F. Mearin, Antonio Gasbarrini, Jan Tack. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseasesDigestive and Liver Disease 2018; 50(8): 741 doi: 10.1016/j.dld.2018.04.020
15
Jérémie Jacques, Paul Carrier, Marilyne Debette-Gratien, Rodolphe Sobesky, Véronique Loustaud-Ratti. Encéphalopathie hépatiqueLa Presse Médicale 2016; 45(1): 46 doi: 10.1016/j.lpm.2015.02.021
16
Arumugam R. Jayakumar, Xiao Y. Tong, Kevin M. Curtis, Roberto Ruiz‐Cordero, Maria T. Abreu, Michael D. Norenberg. Increased toll‐like receptor 4 in cerebral endothelial cells contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathyJournal of Neurochemistry 2014; 128(6): 890 doi: 10.1111/jnc.12516
17
Patricia P. Bloom, Elliot B. Tapper, Vincent B. Young, Anna S. Lok. Microbiome therapeutics for hepatic encephalopathyJournal of Hepatology 2021; 75(6): 1452 doi: 10.1016/j.jhep.2021.08.004
18
Felipe Toyama Aires, Paola Teruya Ramos, Wanderley Marques Bernardo. Efficacy of lactulose in the prophylaxis of hepatic encephalopathy in cirrhotic patients presenting gastrointestinal bleedingRevista da Associação Médica Brasileira 2016; 62(3): 243 doi: 10.1590/1806-9282.62.03.243
19
Noriaki Naeshiro, Hideaki Kakizawa, Hiroshi Aikata, Hiromi Kan, Hatsue Fujino, Takayuki Fukuhara, Tomoki Kobayashi, Yohji Honda, Daisuke Miyaki, Tomokazu Kawaoka, Masataka Tsuge, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Hideyuki Hyogo, Masaki Ishikawa, Kazuo Awai, Kazuaki Chayama. Percutaneous transvenous embolization for portosystemic shunts associated with encephalopathy: Long‐term outcomes in 14 patientsHepatology Research 2014; 44(7): 740 doi: 10.1111/hepr.12181
20
Herbert L. DuPont. Therapeutic Effects and Mechanisms of Action of Rifaximin in Gastrointestinal DiseasesMayo Clinic Proceedings 2015; 90(8): 1116 doi: 10.1016/j.mayocp.2015.04.016
21
Sung-Min Won, Eunju Park, Jin-Ju Jeong, Raja Ganesan, Haripriya Gupta, Yoseph Gebru, SatyaPriya Sharma, Dong-Joon Kim, Ki-Tae Suk. The Gut Microbiota-Derived Immune Response in Chronic Liver DiseaseInternational Journal of Molecular Sciences 2021; 22(15): 8309 doi: 10.3390/ijms22158309
22
Kakulavarapu V. Rama Rao, Arumugam R. Jayakumar, Michael D. Norenberg. Brain edema in acute liver failure: mechanisms and conceptsMetabolic Brain Disease 2014; 29(4): 927 doi: 10.1007/s11011-014-9502-y
23
Michael W. Rowley, Myunghan Choi, Steve Chen, Kevin Hirsch, Anil B. Seetharam. Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with RevisionCardioVascular and Interventional Radiology 2018; 41(11): 1765 doi: 10.1007/s00270-018-1992-2
24
Michael W. Rowley, Myunghan Choi, Steve Chen, Kevin Hirsch, Anil B. Seetharam. Race and Gradient Difference Are Associated with Increased Risk of Hepatic Encephalopathy Hospital Admission After Transjugular Intrahepatic Portosystemic Shunt PlacementJournal of Clinical and Experimental Hepatology 2018; 8(3): 256 doi: 10.1016/j.jceh.2017.12.003
25
Makoto Usami, Makoto Miyoshi, Hayato Yamashita. Gut microbiota and host metabolism in liver cirrhosisWorld Journal of Gastroenterology 2015; 21(41): 11597-11608 doi: 10.3748/wjg.v21.i41.11597
26
Fengfei Sun, Junfeng Chen, Kai Liu, Meizhen Tang, Yuewei Yang. The avian gut microbiota: Diversity, influencing factors, and future directionsFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.934272
27
Andrew G. Taylor, Kanti P. Kolli, Robert K. Kerlan. Techniques for Transjugular Intrahepatic Portosystemic Shunt Reduction and OcclusionTechniques in Vascular and Interventional Radiology 2016; 19(1): 74 doi: 10.1053/j.tvir.2016.01.008
28
G. Vassallo, A. Mirijello, A. Ferrulli, M. Antonelli, R. Landolfi, A. Gasbarrini, G. Addolorato. Review article: alcohol and gut microbiota ‐ the possible role of gut microbiota modulation in the treatment of alcoholic liver diseaseAlimentary Pharmacology & Therapeutics 2015; 41(10): 917 doi: 10.1111/apt.13164
29
Eamonn M Quigley, Howard P Monsour. The gut microbiota and the liver: implications for clinical practiceExpert Review of Gastroenterology & Hepatology 2013; 7(8): 723 doi: 10.1586/17474124.2013.848167
30
Rahul Rai, Vivek A. Saraswat, Radha K. Dhiman. Gut Microbiota: Its Role in Hepatic EncephalopathyJournal of Clinical and Experimental Hepatology 2015; 5: S29 doi: 10.1016/j.jceh.2014.12.003
31
Daniela Campion, Ilaria Giovo, Paola Ponzo, Giorgio M Saracco, Federico Balzola, Carlo Alessandria. Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosisWorld Journal of Hepatology 2019; 11(6): 489-512 doi: 10.4254/wjh.v11.i6.489
32
Leon Louis Seifert, Philipp Schindler, Martin Schoster, Jan Frederic Weller, Christian Wilms, Hartmut H. Schmidt, Miriam Maschmeier, Max Masthoff, Michael Köhler, Hauke Heinzow, Moritz Wildgruber. Recurrence of Hepatic Encephalopathy after TIPS: Effective Prophylaxis with Combination of Lactulose and RifaximinJournal of Clinical Medicine 2021; 10(20): 4763 doi: 10.3390/jcm10204763
33
Lucia Giuli, Marta Maestri, Francesco Santopaolo, Maurizio Pompili, Francesca Romana Ponziani. Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver DiseaseMetabolites 2023; 13(6): 772 doi: 10.3390/metabo13060772
34
Ming Luo, Jian-Yang Guo, Wu-Kui Cao. Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosisWorld Journal of Gastroenterology 2015; 21(41): 11815-11824 doi: 10.3748/wjg.v21.i41.11815
35
Tamalika Chakraborty, Jeenatara Begum, Dipanjan Mandal, Abhijit Sengupta. Advances in Probiotics2021; : 203 doi: 10.1016/B978-0-12-822909-5.00013-7
36
Wei-Wei Wang, Yu Zhang, Xiao-Bing Huang, Nan You, Lu Zheng, Jing Li. Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunctionWorld Journal of Gastroenterology 2017; 23(38): 6983-6994 doi: 10.3748/wjg.v23.i38.6983
37
Ramzi Hassouneh, Jasmohan S. Bajaj. Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy TreatmentJournal of Clinical Medicine 2021; 10(2): 330 doi: 10.3390/jcm10020330
38
Rohan Dalal, Richard G McGee, Stephen M Riordan, Angela C Webster. Probiotics for people with hepatic encephalopathyCochrane Database of Systematic Reviews 2017; 2021(1) doi: 10.1002/14651858.CD008716.pub3
39
Alberto Nicoletti, Francesca Romana Ponziani, Marco Biolato, Venanzio Valenza, Giuseppe Marrone, Gabriele Sganga, Antonio Gasbarrini, Luca Miele, Antonio Grieco. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantationWorld Journal of Gastroenterology 2019; 25(33): 4814-4834 doi: 10.3748/wjg.v25.i33.4814
40
Cinzia Signorini, Claudio De Felice, Silvia Leoncini, Thierry Durand, Jean-Marie Galano, Alessio Cortelazzo, Gloria Zollo, Roberto Guerranti, Stefano Gonnelli, Carla Caffarelli, Marcello Rossi, Alessandra Pecorelli, Giuseppe Valacchi, Lucia Ciccoli, Joussef Hayek. Altered erythrocyte membrane fatty acid profile in typical Rett syndrome: Effects of omega-3 polyunsaturated fatty acid supplementationProstaglandins, Leukotrienes and Essential Fatty Acids 2014; 91(5): 183 doi: 10.1016/j.plefa.2014.08.002
41
Leigh C. Casadaban, Ahmad Parvinian, Jeet Minocha, Janesh Lakhoo, Christopher W. Grant, Charles E. Ray, M. Grace Knuttinen, James T. Bui, Ron C. Gaba. Clearing the Confusion over Hepatic Encephalopathy After TIPS Creation: Incidence, Prognostic Factors, and Clinical OutcomesDigestive Diseases and Sciences 2015; 60(4): 1059 doi: 10.1007/s10620-014-3391-0
42
Stephen D. H. Malnick, David Fisher, Marina Somin, Manuela G. Neuman. Treating the Metabolic Syndrome by Fecal Transplantation—Current StatusBiology 2021; 10(5): 447 doi: 10.3390/biology10050447